Synonyms: ASL-603 | bretylium tosylate | Bretylol®
bretylium is an approved drug
Compound class:
Synthetic organic
Comment: Bretylium is a substrate for the noradrenaline transporter so it accumulates inside nerve terminals which have this transporter. This accumulation underlies its inhibitory action on the sympathetic nervous system. Bretylium tosylate is no longer available in the US.
View more information in the IUPHAR Pharmacology Education Project: bretylium |
|
Classification | |
Compound class | Synthetic organic |
Approved drug? | Yes |
IUPAC Name |
[(2-bromophenyl)methyl](ethyl)dimethylazanium |
International Nonproprietary Names | |
INN number | INN |
927 | bretylium tosilate |
Synonyms |
ASL-603 | bretylium tosylate | Bretylol® |
Database Links | |
CAS Registry No. | 61-75-6 |
ChEMBL Ligand | CHEMBL1199080 |
DrugBank Ligand | DB01158 |
DrugCentral Ligand | 394 |
GtoPdb PubChem SID | 178103706 |
PubChem CID | 2431 |
Search Google for chemical match using the InChIKey | AAQOQKQBGPPFNS-UHFFFAOYSA-N |
Search Google for chemicals with the same backbone | AAQOQKQBGPPFNS |
Search PubMed clinical trials | bretylium tosilate |
Search PubMed titles | bretylium tosilate |
Search PubMed titles/abstracts | bretylium tosilate |
UniChem Compound Search for chemical match using the InChIKey | AAQOQKQBGPPFNS-UHFFFAOYSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | AAQOQKQBGPPFNS-UHFFFAOYSA-N |
Wikipedia | Bretylium |